Author:
Abdou Yara,Gupta Medhavi,Asaoka Mariko,Attwood Kristopher,Mateusz Opyrchal,Gandhi Shipra,Takabe Kazuaki
Abstract
AbstractBreast cancer is more common on the left side than the right side. We aim to evaluate differences in clinicopathological and genomic characteristics based on laterality. We analyzed survival outcomes and clinical characteristics of 881,320 patients recorded by the Surveillance, Epidemiology, and End Results (SEER) program. The Cancer Genome Atlas (TCGA) was used to explore genomic and clinical features from 1,062 patients. Gene expression data was used to quantitate cytolytic activity and hallmark gene-sets were used for gene set enrichment analysis. An institutional retrospective review was conducted on 155 patients treated with neoadjuvant chemotherapy (NACT). Patient characteristics were summarized by pathological complete response (pCR). Left sided tumors were found to be more prevalent than right sided tumors. No major clinicopathological differences were noted by laterality. Left sided breast cancer demonstrated poorer outcomes versus right sided tumors (HR 1.05, 95% CI 1.01–1.08; p = 0.011). Cell proliferation gene sets, including E2F Targets, G2M Checkpoint, Mitotic spindle, and MYC Targets, were enriched on the left side compared to the right. Left sided tumors had lower pCR rates versus right sided tumors (15.4% versus 29.9%, p = 0.036). Our findings suggest that left sided breast cancer is associated with aggressive biology and worse outcomes compared to right sided breast cancer.
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. von Fellenberg, R. Schweiz. Erhebung Fiber Maligne Tumoren [Switzerland Survey of malignant tumors] (Bull Eidgenoss Gesundheitsamt, 1940).
2. Amer, M. H. Genetic factors and breast cancer laterality. Cancer Manag. Res. 6, 191–203 (2014).
3. Perkins, C. I., Hotes, J., Kohler, B. A. & Howe, H. L. Association between breast cancer laterality and tumor location, United States, 1994–1998. Cancer Causes Control 15, 637–645 (2004).
4. Cheng, S.-A. et al. Breast cancer laterality and molecular subtype likely share a common risk factor. Cancer Manag. Res. 10, 6549–6554 (2018).
5. Roychoudhuri, R., Putcha, V. & Møller, H. Cancer and laterality: A study of the five major paired organs (UK). Cancer Causes Control 17, 655–662 (2006).
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献